HK1213594A1 - 免疫原性組合物及其用途 - Google Patents
免疫原性組合物及其用途Info
- Publication number
- HK1213594A1 HK1213594A1 HK15112748.3A HK15112748A HK1213594A1 HK 1213594 A1 HK1213594 A1 HK 1213594A1 HK 15112748 A HK15112748 A HK 15112748A HK 1213594 A1 HK1213594 A1 HK 1213594A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- immunogenic compositions
- immunogenic
- compositions
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1009—Picornaviridae, e.g. hepatitis A virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32351—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32361—Methods of inactivation or attenuation
- C12N2770/32363—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/858,007 US9051361B2 (en) | 2010-08-17 | 2010-08-17 | Immunogenic compositions and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1213594A1 true HK1213594A1 (zh) | 2016-07-08 |
Family
ID=45594260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15112748.3A HK1213594A1 (zh) | 2010-08-17 | 2012-09-25 | 免疫原性組合物及其用途 |
Country Status (4)
Country | Link |
---|---|
US (1) | US9051361B2 (zh) |
CN (2) | CN102399757A (zh) |
HK (1) | HK1213594A1 (zh) |
TW (1) | TWI481717B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013131496A1 (zh) * | 2012-03-09 | 2013-09-12 | 中国科学院上海巴斯德研究所 | 治疗病毒疾病的成分和方法 |
CN104694479B (zh) * | 2012-07-13 | 2018-05-04 | 厦门大学 | 肠道病毒71型的vp2抗原的中和表位多肽及其用途 |
MA41506A (fr) * | 2015-02-13 | 2017-12-19 | Takeda Vaccines Inc | Procédés de production de virus pour produire des vaccins |
EP3085774A1 (en) * | 2015-04-20 | 2016-10-26 | QIAGEN GmbH | Method for concentrating, purifying and/or isolating virus particles |
CN105759033A (zh) * | 2016-03-29 | 2016-07-13 | 中国医学科学院医学生物学研究所 | 一种Cox A16及EV71病毒抗原的鉴别检测方法 |
CN106119209B (zh) * | 2016-07-01 | 2019-10-25 | 武汉爱博泰克生物科技有限公司 | 一种抗肠道病毒EV71 IgA单克隆抗体及应用 |
CN106421770B (zh) * | 2016-11-11 | 2019-12-06 | 中山大学 | 包含ev71vp1蛋白的纳米颗粒及其制备方法 |
KR102673090B1 (ko) * | 2017-07-03 | 2024-06-05 | 브하라트 바이오테크 인터내셔날 리미티드 | 합성 폴리펩타이드 에피토프 기반의 백신 조성물 |
CN108267577B (zh) * | 2018-01-15 | 2020-10-09 | 广州市妇女儿童医疗中心 | 一种EV71病毒IgA抗体检测试纸条 |
CN109929032A (zh) * | 2019-02-26 | 2019-06-25 | 青岛今墨堂生物技术有限公司 | 一种抗手足口病鸡卵黄抗体的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5719051A (en) | 1989-12-22 | 1998-02-17 | Immuno Aktiengesellschaft | Perfusion system and a method for the large scale production of virus or virus antigen |
DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
KR100999316B1 (ko) * | 2003-06-09 | 2010-12-10 | 와이어쓰 엘엘씨 | cDNA로부터의 비분절 네가티브 쇄 RNA 바이러스의회수를 위한 개선된 방법 |
CN101402944B (zh) * | 2008-11-17 | 2010-12-22 | 中国医学科学院医学生物学研究所 | 一种ev-71病毒毒种、人用灭活疫苗及其制备方法 |
US8168192B2 (en) * | 2008-11-19 | 2012-05-01 | National Chung Hsing University | Enterovirus type 71 protein and method for production |
CN101717754B (zh) * | 2009-12-30 | 2012-09-05 | 北京科兴生物制品有限公司 | 一种71型肠道病毒及其应用 |
-
2010
- 2010-08-17 US US12/858,007 patent/US9051361B2/en active Active
- 2010-10-27 TW TW099136764A patent/TWI481717B/zh active
-
2011
- 2011-08-17 CN CN2011102423986A patent/CN102399757A/zh active Pending
- 2011-08-17 CN CN201510239613.5A patent/CN104946604A/zh active Pending
-
2012
- 2012-09-25 HK HK15112748.3A patent/HK1213594A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN102399757A (zh) | 2012-04-04 |
US9051361B2 (en) | 2015-06-09 |
TWI481717B (zh) | 2015-04-21 |
US20120045468A1 (en) | 2012-02-23 |
TW201209166A (en) | 2012-03-01 |
CN104946604A (zh) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL277110A (en) | Immunogenic anti-inflammatory preparations | |
ZA201209259B (en) | Uses and compositions | |
GB201003924D0 (en) | Immunogenic composition | |
GB201006096D0 (en) | Novel compositions and uses thereof | |
EP2646468A4 (en) | ANTI-NGF COMPOSITIONS AND THEIR USE | |
EP2550307A4 (en) | MACRO-PHOTOINITIATORS AND COMPOSITIONS CURABLE THEREOF | |
IL223153A0 (en) | Compositions comprising acid and derivatives thereof and uses thereof | |
EP2547373A4 (en) | NANOTUBES AND ASSOCIATED COMPOSITIONS | |
EP2629742A4 (en) | HAIR CARE COMPOSITIONS AND RELATED METHODS | |
ZA201209739B (en) | Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof | |
PT2605757E (pt) | Formulações à base de nalbufina e suas utilizações | |
PL2579839T3 (pl) | Kompozycje perfumeryjne i ich zastosowania | |
HK1213594A1 (zh) | 免疫原性組合物及其用途 | |
GB201015132D0 (en) | Vaccine composition | |
EP2416801A4 (en) | IMMUNOGENIC COMPOSITION AND ITS USES | |
GB201005625D0 (en) | Immunogenic proteins and compositions | |
GB201113770D0 (en) | Novel compositions and uses thereof | |
HK1173657A1 (zh) | 免疫組合物和方法 | |
EP2515940A4 (en) | IMMUNOGENIC COMPOSITIONS AND CORRESPONDING METHODS | |
GB201103423D0 (en) | Immunogenic proteins and compositions | |
EP2525818A4 (en) | IMMUNOGENIC COMPOSITION OF INFLUENZA VIRUSES | |
EP2609931A4 (en) | IMMUNOGENIC COMPOSITION | |
HK1201451A1 (zh) | 組合物及其製備方法 | |
GB201018650D0 (en) | Methods and compositions | |
EP2588118A4 (en) | IMMUNOGENICALLY CONSTRAINED COMPOSITIONS AND THEIR APPLICATIONS |